{"id":"W2590722941","doi":"10.1200/jco.2013.31.4_suppl.226","title":"Quality of life in a multicenter phase II trial of neoadjuvant full-dose gemcitabine, oxaliplatin, and radiation in patients with resectable or borderline resectable pancreatic adenocarcinoma.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Toronto General Hospital; University of Toronto","funders":"","keywords":"Medicine; Gemcitabine; Oxaliplatin; Internal medicine; Pancreatic cancer; Neoadjuvant therapy; Adenocarcinoma; Radiation therapy; Chemotherapy; Clinical endpoint; Pancreatectomy; Quality of life (healthcare); Oncology; Surgery; Clinical trial; Gastroenterology; Cancer; Pancreas; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003509198,0.0009645022,0.001195456,0.0002419868,0.0003556204,0.0007687074,0.0005516254,0.0007701941,0.001804584],"category_scores_gemma":[0.001584857,0.0004927036,0.001195565,0.000322121,0.0007771556,0.0005950463,0.0004562211,0.001984952,0.0002946935],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006522699,"about_ca_system_score_gemma":0.001092391,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003902419,"about_ca_topic_score_gemma":0.001001147,"domain_scores_codex":[0.9989741,0.0007545985,0.00005334236,0.00008501791,0.0000467486,0.00008616762],"domain_scores_gemma":[0.9988412,0.0002644164,0.0003294779,0.00009568822,0.00005209563,0.0004170706],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9107442,0.03519394,0.01323111,0.0003513547,0.0008714693,0.0000974836,0.0001983031,0.001289457,0.009297455,0.00006424577,0.0008319283,0.02782913],"study_design_scores_gemma":[0.5061289,0.4692306,0.02056768,0.00003312064,0.0004596642,0.0001424958,0.00006363601,0.001127067,0.001432297,0.00006956066,0.0007255228,0.00001937183],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9982854,0.0005866881,0.0001312279,0.0001555907,0.00004076003,0.0004434981,0.0001331658,0.00000999279,0.0002136418],"genre_scores_gemma":[0.9966517,0.0003913827,0.000584421,0.0003258822,0.00007381382,0.001089029,0.000535941,0.000006018785,0.000341823],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003509198,"threshold_uncertainty_score":0.01855862,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1157003720393044,"score_gpt":0.4743228696421602,"score_spread":0.3586224976028559,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}